Clindamycin News and Research

RSS

Preserved placenta is associated with risk of infection

A recent case study published by Centers for Disease Control and Prevention highlighted that capsules of dehydrated placenta prepared for human consumption can be a source of infectious agents.

30 Jun 2017

Antibiotics found to be effective for treating simple skin abscesses in adults and children

New multicenter research, which included Vanderbilt University Medical Center investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria.

30 Jun 2017

Common, inexpensive antimicrobials can help patients heal from MRSA skin abscesses

Methicillin-resistant Staphylococcus aureus (MRSA) bacteria are resistant to multiple antibiotics and commonly cause skin infections that can lead to more serious or life-threatening infection in other parts of the body.

29 Jun 2017

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.

5 Jun 2017

New class of antibiotics effective in treating children with MRSA skin infections

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge. As its name suggests, MRSA is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes complicated skin and skin structure infections.

17 Feb 2017

International travellers may spread antimicrobial-resistant bacteria in their home countries, study reveals

Airports are international travel hubs visited by large numbers of people. London Heathrow, for example, has an average of 205,400 travellers every day and saw 75 million people arriving and departing from all over the world in 2015.

3 Nov 2016

Pathogen-selective approach to antibiotic development less disruptive to gut microbiome

St. Jude Children's Research Hospital scientists report the first evidence that a pathogen-specific antibiotic was less disruptive to the gut microbiome than broad-spectrum antibiotics.

10 May 2016

Maternal bacterial infections affect fetal brain anatomy and cognitive functioning after birth

St. Jude Children's Research Hospital scientists have discovered how pieces of bacterial cell wall cross the placenta and enter developing neurons, altering fetal brain anatomy and cognitive functioning after birth. The study appears today in the scientific journal Cell Host & Microbe.

10 Mar 2016

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Antibiotics that fight infection can adversely affect the digestive tract and give destructive bacteria a chance to flourish, said assistant professor of veterinary and biomedical sciences Joy Scaria of South Dakota State University. His research seeks to identify probiotic mixes to treat intestinal infections, such as Clostridium difficile.

12 Jan 2016

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

New research from North Carolina State University and the University of Michigan finds that bile acids which are altered by bacteria normally living in the large intestine inhibit the growth of Clostridium difficile, or C. diff. C. diff is a harmful bacterium that can cause painful and sometimes fatal infections.

7 Jan 2016

Two common antibiotic treatments equally effective against MRSA skin infections

Researchers funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have found that two common antibiotic treatments work equally well against bacterial skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA) acquired outside of hospital settings.

20 Mar 2015

New microarray-based tool provides fast, reliable assessment of vaginal health

A new microarray-based tool, called VaginArray, offers the potential to provide a fast, reliable and low-cost assessment of vaginal health and diagnoses of infections. The research is published ahead of print March 2, in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.

19 Mar 2015

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

9 Jun 2014

Research: Reducing antibiotics consumption does not necessarily reduce resistance

Antibiotic use-and misuse-is the main driver for selection of antibiotic resistant bacteria. This has led many countries to implement interventions designed to reduce overall antibiotic consumption. Now, using methicillin resistant Staphylococcus aureus (MRSA) as an example, Laura Temime of the Conservatoire National des Arts et Metiers, Paris, and collaborators warn that simply reducing antibiotics consumption does not necessarily reduce resistance.

30 Jul 2013

Infection control program and active surveillance can reduce incidence of impatient C. diff infections

A comprehensive infection control program combined with an active surveillance process significantly reduced the incidence of Clostridium difficile (C. diff) infections in a long-term acute care hospital, according to a study published in the Journal for Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ).

10 Jul 2013

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Synthetic biology researchers at Northwestern University, working with partners at Harvard Medical School, have for the first time synthesized ribosomes -- cell structures responsible for generating all proteins and enzymes in our bodies -- from scratch in a test tube.

30 Jun 2013

Clindamycin News and Research

Preserved placenta is associated with risk of infection

Antibiotics found to be effective for treating simple skin abscesses in adults and children

Common, inexpensive antimicrobials can help patients heal from MRSA skin abscesses

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

New class of antibiotics effective in treating children with MRSA skin infections

International travellers may spread antimicrobial-resistant bacteria in their home countries, study reveals

Pathogen-selective approach to antibiotic development less disruptive to gut microbiome

Maternal bacterial infections affect fetal brain anatomy and cognitive functioning after birth

Researcher seeks to identify probiotic mixes to treat Clostridium difficile infections

Common antibiotics can promote C. diff infections by killing off bile acid-altering microbes

Two common antibiotic treatments equally effective against MRSA skin infections

New microarray-based tool provides fast, reliable assessment of vaginal health

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Research: Reducing antibiotics consumption does not necessarily reduce resistance

Infection control program and active surveillance can reduce incidence of impatient C. diff infections

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Akorn reports record consolidated revenue of $73.9 million in first quarter 2013

Osteomyelitis guidelines push pediatric care

Medication use and doctor visits drive up jaw necrosis-related costs

Mylan acquires two dermatological drugs from Valeant

Hasret Altan-Martin

Speeding Up Sample Preparation to Accelerate Analytical Chemistry

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Latest News

Neuroscience eBook